Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
New Nonprofit Founded by Leading Testosterone Experts Seeks to Provide Equal Access to Care for Both Men and WomenRALEIGH, N.C., Nov. 15, 2024 (GLOBE NEWSWIRE) -- The Testosterone Project, a new ...
Parking has long been a frustrating endeavor in the Texas Medical Center, a nonprofit that operates 20 parking garages and about 28,000 total spaces throughout its sprawling 1,300-acre campus. Just ...
Has executed a definitive agreement with Stella, an interventional psychiatry practice focused on treating PTSD, anxiety and depression with biological modalities, for the sale of the Company's five ...